Cargando…
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
BACKGROUND: Drug resistance is a considerable challenge for chemotherapy in non-small cell lung cancer (NSCLC). Propofol, a commonly used intravenous anesthetics, has been reported to suppress the malignancy of various cancers. However, the effects of propofol on cisplatin (DDP) sensitivity in NSCLC...
Autores principales: | Ling, Quan, Wu, Shaoyong, Liao, Xiaozu, Liu, Chiyi, Chen, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281112/ https://www.ncbi.nlm.nih.gov/pubmed/35836137 http://dx.doi.org/10.1186/s12885-022-09848-y |
Ejemplares similares
-
MiR‐192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF‐κB pathway
por: Li, Yang, et al.
Publicado: (2021) -
Propofol inhibits lung cancer cell viability and induces cell apoptosis
by upregulating microRNA-486 expression
por: Yang, N., et al.
Publicado: (2017) -
SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis
por: Liu, Fei, et al.
Publicado: (2018) -
Anesthetic Propofol Reduces Endotoxic Inflammation by Inhibiting Reactive Oxygen Species-regulated Akt/IKKβ/NF-κB Signaling
por: Hsing, Chung-Hsi, et al.
Publicado: (2011) -
MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation
por: Tang, Qisheng, et al.
Publicado: (2020)